Skip to main content

Table 2 Distributional characteristics of UFS-QOL scale scores at baseline and after 12 weeks of treatment

From: Psychometric validation of the 1-month recall Uterine Fibroid Symptom and Health-Related Quality of Life questionnaire (UFS-QOL)

  VENUS I VENUS II
Baseline (n = 157) 12 weeks (n = 135a) Baseline (n = 429b) 12 weeks (n = 347)
UFS-QOL Mean (SD) Median (range) Mean (SD) Median (range) Mean (SD) Median (range) Mean (SD) Median (range)
Symptom Severityc 62.0 (19.7) 63 (0–100) 30.5 (24.5) 25 (0–100) 65.5 (21.5) 69 (3–100) 33.0 (25.8) 28 (0–100)
Concernd 22.9 (22.6) 15 (0–100) 66.1 (35.7) 80 (0–100) 21.0 (21.7) 15 (0–100) 66.1 (35.9) 75 (0–100)
Activitiesd 34.3 (24.6) 32 (0–100) 75.4 (29.3) 89 (0–100) 32.0 (25.7) 29 (0–100) 71.7 (32.2) 86 (0–100)
Revised Activitiesd 30.7 (24.8) 30 (0–100) 74.4 (30.5) 85 (0–100) 29.9 (25.9) 25 (0–100) 71.1 (32.9) 85 (0–100)
Energy/Moodd 37.3 (24.7) 32 (0–100) 74.3 (27.5) 82 (4–100) 34.6 (25.0) 32 (0–100) 69.0 (29.6) 75 (0–100)
Controld 45.0 (27.0) 45 (0–100) 77.7 (26.9) 85 (0–100) 43.3 (28.8) 40 (0–100) 73.9 (30.4) 85 (0–100)
Self-Consciousnessd 35.1 (28.9) 33 (0–100) 71.4 (29.6) 83 (0–100) 31.7 (29.4) 25 (0–100) 62.9 (34.1) 67 (0–100)
Sexual Functiond 40.3 (33.8) 38 (0–100) 72.0 (33.5) 88 (0–100) 37.7 (33.7) 25 (0–100) 66.5 (35.4) 75 (0–100)
HRQoL Totald 35.4 (21.4) 35 (0–100) 73.3 (26.9) 81 (4–100) 33.0 (22.3) 29 (0–97) 69.2 (29.6) 78 (0–100)
  1. an = 134 for Symptom Severity, Concern, Energy/Mood, Control, Sexual Function, and HRQoL Total
  2. bn = 428 for Activities, Revised Activities, and Self-Consciousness; n = 427 for Concern, Energy/Mood, and Control; n = 426 for Sexual Function and HRQoL Total
  3. cScores range from 0 to 100, higher scores indicate greater symptom severity
  4. dScores range from 0 to 100, higher scores indicate better HRQoL. HRQoL health-related quality of life; SD standard deviation; UFS-QOL Uterine Fibroid Symptom and Health-Related Quality of Life questionnaire
\